THROMBIN GENERATION TIME A HELPFUL TOOL IN PREDICTING BLEEDING OR THROMBOTIC RISK IN PATIENTS WITH COAGULATION FACTOR DEFICIENCIES

被引：0
|
作者：
Papandrea, Maria [1 ]
Montaruli, Barbara [1 ]
Valesella, Paolo [1 ]
Insana, Antonio [1 ]
Renzi, Nadia [1 ]
Cosseddu, Domenico [1 ]
机构：
[1] AO Mauriziano, SC Lab Anal, Turin, Italy
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2023年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：133 / 133
页数：1
相关论文
共 50 条
  • [31] Prediction of bleeding risk in patients taking vitamin K antagonists using thrombin generation testing
    Bloemen, Saartje
    Zwaveling, Suzanne
    ten Cate, Hugo
    ten Cate-Hoek, Anna
    de laat, Bas
    PLOS ONE, 2017, 12 (05):
  • [32] Detecting Bleeding Risk in Patients Taking Vitamin K Antagonists Using Thrombin Generation Tests
    Bloemen, Saartje
    ten Cate-Hoek, Arina
    ten Cate, Hugo
    De laat, Bas
    BLOOD, 2014, 124 (21)
  • [33] Investigation of patients with unclassified bleeding disorder and abnormal thrombin generation for physiological coagulation inhibitors reveals multiple abnormalities and a subset of patients with increased tissue factor pathway inhibitor activity
    MacDonald, Stephen
    White, Danielle
    Langdown, Jon
    Downes, Kate
    Thomas, Will
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) : 246 - 255
  • [34] Haernophilia patients exhibit prolonged coagulation time but normal lag time of thrombin generation test:: Are these results really discordant?
    Dargaud, Yesinn
    Bordet, Jean Claude
    Francillon, Stephanie
    Negrier, Claude
    THROMBOSIS AND HAEMOSTASIS, 2007, 97 (04) : 675 - 676
  • [35] Relationship between plasma tissue Factor Pathway Inhibitor (TFPI) levels, thrombin generation and clinical risk of bleeding in patients with severe haemophilia A or B
    Tardy-Poncet, Brigitte
    Montmartin, Aurelie
    Chambost, Herve
    Lienhart, Anne
    Frotscher, Birgit
    Morange, Pierre-Emmanuel
    Falaise, Celine
    Collange, Fanny
    Dargaud, Yesim
    Toussaint-Hacquard, Marie
    Ardillon, Laurent
    Wibaut, Benedicte
    Jeanpierre, Emmanuelle
    Nguyen, Philippe
    Volot, Fabienne
    Tardy, Bernard
    HAEMOPHILIA, 2024, 30 (03) : 693 - 701
  • [36] Thrombin Generation as a Method to Identify the Risk of Bleeding in High Clinical-Risk Patients Using Dual Antiplatelet Therapy
    de Breet, C. P. D. M.
    Zwaveling, S.
    Vries, M. J. A.
    van Oerle, R. G.
    Henskens, Y. M. C.
    Van't Hof, A. W. J.
    van der Meijden, P. E. J.
    Veenstra, L.
    ten Cate, H.
    Olie, R. H.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [37] The whole blood thrombin generation test predicts bleeding risk in patients taking vitamin K antagonists
    Bloemen, S.
    ten Cate-Hoek, A.
    ten Cate, H.
    de Laat, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 259 - 259
  • [38] Thrombin Generation Assay in Hospitalized Nonsurgical Patients: A New Tool to Assess Venous Thromboembolism Risk?
    Espitia, Olivier
    Fouassier, Marc
    Hardouin, Jean-Benoit
    Pistorius, Marc-Antoine
    Agard, Christian
    Planchon, Bernard
    Trossaert, Marc
    Pottier, Pierre
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (01) : 45 - 51
  • [39] Thrombomodulin inhibits tissue factor-induced thrombin generation in plasma of patients with disseminated intravascular coagulation.
    Wada, H
    Nobori, T
    Sakakura, M
    Kushiya, F
    Shiku, H
    BLOOD, 2001, 98 (11) : 78B - 78B
  • [40] Residual platelet factor V ensures thrombin generation in patients with severe congenital factor V deficiency and mild bleeding symptoms
    Duckers, Connie
    Simioni, Paolo
    Spiezia, Luca
    Radu, Claudia
    Dabrilli, Paolo
    Gavasso, Sabrina
    Rosing, Jan
    Castoldi, Elisabetta
    BLOOD, 2010, 115 (04) : 879 - 886
12345